Stephen Sheldon - CFO and COO at Kuvatris Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CFO and COO
Issuer Symbol
PXMD
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Stephen Sheldon since 13 Mar 2025

Holdings reported by Stephen Sheldon for Kuvatris Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 10,137 $6,995 $0.6900 12 Mar 2024 Direct
Common Stock 1,106 $763 $0.6900 12 Mar 2024 The Sheldon Family Trust

Transactions reported by Stephen Sheldon for Kuvatris Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.